tradingkey.logo
tradingkey.logo
Search

Vivos Therapeutics Inc

VVOS
Add to Watchlist
0.453USD
-0.045-9.05%
Close 07/02, 13:00ETQuotes delayed by 15 min
4.21MMarket Cap
LossP/E TTM

More Details of Vivos Therapeutics Inc Company

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Vivos Therapeutics Inc Info

Ticker SymbolVVOS
Company nameVivos Therapeutics Inc
IPO dateDec 11, 2020
CEOHuntsman (R. Kirk)
Number of employees109
Security typeOrdinary Share
Fiscal year-endDec 11
Address7921 Southpark Plaza,
CityLITTLETON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80120
Phone18669084867
Websitehttps://vivos.com/
Ticker SymbolVVOS
IPO dateDec 11, 2020
CEOHuntsman (R. Kirk)

Company Executives of Vivos Therapeutics Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Vivos Therapeutics Inc?

The top five shareholders of Vivos Therapeutics Inc are: Mr. Bradford K. (Brad) Amman

How many institutions hold shares of Vivos Therapeutics Inc (VVOS)?

As of 2026Q1, 50 institutions hold shares of Vivos Therapeutics Inc, with a combined market value of approximately 1.10M, accounting for 8.12% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -71775.00.

What is the biggest source of revenue for Vivos Therapeutics Inc?

In 2026Q1, the Sleep testing services business generated the highest revenue for Vivos Therapeutics Inc, amounting to 2.56M and accounting for 37.74% of total revenue.